retatrutide dosage phase 2 trial Let's talk about a new weight loss medication: retrarutide. is a triple hormone receptor agonist that suppresses appetite; it also boosts metabolism and increases fat burning, making it one of the Retatrutide, Part 2: Examining The

With microdosing, patients begin at the lowest effective amount of the medication and increase the dosage more slowly

These are compounded products that is, made by specialized pharmacists instead of a drug company

The trial evaluated retatrutide, an investigational triple-hormone therapy targeting GIP, GLP-1 and glucagon receptors

Potential long-term risks include pancreatitis, gallbladder disease, lean muscle mass loss, and early worsening of diabetic retinopathy with rapid glycaemic improvement

The drug will likely come in pens with pre-measured doses, similar to other weight loss injections

It doesn't bind to androgen receptors or block testosterone synthesis in the way some other compounds do